Craniopharyngioma is a benign but locally aggressive epithelial tumor located in the sellar and suprasellar region (WHO Grade I). It arises from Rathke's pouch remnants and shows a bimodal age distribution in childhood and adulthood. Two histological subtypes exist: adamantinomatous (common in children, calcified, cystic) and papillary (common in adults, solid, rarely calcified). Due to close proximity to the hypothalamus, optic chiasm, and pituitary stalk, it is associated with significant endocrine and visual morbidities. Long-term follow-up is required due to high recurrence rates (20-50%).
Age Range
5-70
Peak Age
10
Gender
Equal
Prevalence
Uncommon
Craniopharyngioma arises from epithelial cell remnants persisting after obliteration of Rathke's pouch during embryological development. The adamantinomatous type contains multilayered squamous epithelial cells similar to ameloblastoma, wet keratin, and dystrophic calcification; the cystic fluid has a 'machine oil' consistency due to cholesterol crystals and protein degradation products, producing characteristic T1 hyperintense signal — this feature is one of the most important MRI findings for craniopharyngioma diagnosis. The papillary type is predominantly solid with rare calcification and minimal cystic change. Suprasellar tumor growth results in optic chiasm compression (bitemporal hemianopia), hypothalamic invasion (diabetes insipidus, obesity, thermoregulation dysfunction), and pituitary stalk compression (panhypopituitarism). Calcifications are the best CT diagnostic clue and are seen in up to 90% of adamantinomatous type but less than 10% of papillary type. The adherent nature of the tumor to surrounding structures makes total resection difficult and recurrence rate high.
The combination of a calcified (CT) cystic + solid mass in the sellar/suprasellar region with T1 hyperintense signal in the cystic component ('machine oil') is pathognomonic for craniopharyngioma. When calcification presence (CT) and T1 hyperintense cyst signal (MRI) are evaluated together, diagnostic certainty reaches the highest level.
On non-contrast CT, a calcified mass in the sellar/suprasellar region is seen. Calcification pattern is present in up to 90% of adamantinomatous type and may be eggshell (peripheral), coarse (clustered), or nodular. Cystic components are hypodense on CT (5-25 HU) but may be denser than pure fluid due to high protein content. The solid component appears isodense to mildly hyperdense. Hydrocephalus (foramen of Monro obstruction) may accompany. The presence and pattern of calcification is the most reliable CT diagnostic feature of craniopharyngioma and is critically important for differentiation from Rathke's cleft cyst.
Report Sentence
A cystic-solid mass with prominent calcifications in the sellar/suprasellar region is observed, compatible with craniopharyngioma.
On contrast-enhanced CT, the solid component and cyst wall show marked enhancement. Enhancement pattern may be rim (along cyst wall) or nodular (within solid mass). Cystic areas do not enhance but are clearly delineated by wall enhancement. Heterogeneous enhancement reflects the tumor's mixed solid-cystic architecture. Contrast-enhanced CT is also important for preoperative assessment of the tumor's relationship with the optic chiasm, carotid arteries, and Circle of Willis.
Report Sentence
Post-contrast, marked enhancement of the solid component and cyst wall is observed, with non-enhancing cystic areas.
On T1-weighted sequences, the cystic component of craniopharyngioma shows characteristic hyperintense signal — this finding reflects the 'machine oil' fluid content of cholesterol crystals, methemoglobin, and proteinaceous debris and is the most diagnostic MRI feature of craniopharyngioma. T1 hyperintense cyst signal may also be seen in Rathke's cleft cyst but the presence of calcification is a critical distinguishing finding favoring craniopharyngioma. The solid component shows isointense to hypointense signal relative to gray matter on T1. Post-contrast, the solid component and cyst wall show marked enhancement. Pre- and post-contrast comparison must always be performed due to the hyperintense cyst.
Report Sentence
The sellar/suprasellar mass demonstrates markedly hyperintense signal in the cystic component on T1-weighted sequences, consistent with proteinaceous/cholesterol-containing cyst fluid.
On T2-weighted sequences, the cystic component of craniopharyngioma shows variable signal: pure serous cysts are T2 hyperintense (CSF-like), proteinaceous cysts show moderate-high signal, and cysts with dense cholesterol/debris content may be T2 hypointense. The solid component shows heterogeneous signal on T2. Peritumoral edema and gliosis may be seen as T2 hyperintense rim. Calcifications appear as low signal foci on T2 (MRI sensitivity for calcification is lower than CT). Optic chiasm compression and third ventricle invasion are best evaluated on T2.
Report Sentence
Variable signal intensity (hyperintense to hypointense) in cystic components and heterogeneous signal in the solid component is observed on T2-weighted sequences.
On FLAIR sequences, the proteinaceous cystic component of craniopharyngioma is not suppressed unlike CSF and remains hyperintense — this feature is a distinguishing finding from arachnoid cyst with pure CSF content. Partial suppression may be seen in serous cyst content. Perilesional gliosis and vasogenic edema appear as hyperintense rim on FLAIR. Hypothalamic invasion is best evaluated on FLAIR; hypothalamic signal change is critically important for determining surgical strategy. FLAIR signal increase along the third ventricle floor and optic tract may indicate tumor spread.
Report Sentence
On FLAIR sequences, the cystic component is not suppressed unlike CSF and remains hyperintense — consistent with proteinaceous cyst content.
On DWI, typical craniopharyngioma does not show significant diffusion restriction — the solid component shows intermediate signal while the cystic component exhibits variable DWI signal. Mild signal increase on DWI may be seen in proteinaceous cyst content due to T2 shine-through effect, but true restriction (low ADC) is not found on ADC map. This feature is critically important for differentiating craniopharyngioma from epidermoid cyst and abscess: epidermoid cyst shows true diffusion restriction (low ADC), craniopharyngioma does not. DWI restriction may be seen when cyst rupture or superimposed infection occurs, increasing clinical urgency.
Report Sentence
No significant diffusion restriction is observed in solid and cystic components on DWI with normal ADC map values — a finding inconsistent with epidermoid cyst.
On MR spectroscopy, dominant lipid (0.9-1.3 ppm) and lactate (1.33 ppm — doublet) peaks are observed in the cystic component of craniopharyngioma. Cholesterol crystals and cell membrane breakdown products are the source of the lipid peak. NAA, choline, and creatine peaks are absent or minimal as cyst fluid does not contain neuronal or glial cells. Low NAA and mildly elevated choline may be seen in the solid component but the typical tumor spectral pattern is indeterminate. This spectral characteristic helps differentiate craniopharyngioma from other sellar region masses (pituitary adenoma — choline dominant, meningioma — alanine peak).
Report Sentence
MR spectroscopy demonstrates dominant lipid-lactate peaks in the cystic component with absent neuronal metabolites (NAA, choline) — consistent with cholesterol-containing cyst fluid.
On SWI sequences, calcified components of craniopharyngioma show prominent blooming artifact (susceptibility effect). This finding allows MRI detection of calcification and correlates with CT findings. However, SWI cannot definitively distinguish between calcification and hemorrhage — phase images must be evaluated (calcification and hemorrhage products show opposite signal change on phase images). SWI also demonstrates venous structures around the tumor and potential vascular invasion sites. The tumor's relationship with carotid arteries and Circle of Willis can be evaluated on SWI for surgical planning.
Report Sentence
Areas of prominent blooming artifact are observed within the mass on SWI sequences, compatible with calcifications demonstrated on CT.
Criteria
No BRAF V600E mutation, CTNNB1 (β-catenin) mutation common; more prevalent in children (peak 5-15 years), 60-70% of all craniopharyngiomas
Distinct Features
Prominent calcification (90%), large cystic component ('machine oil' — T1 hyperintense), wet keratin, multiloculated cysts, adherent growth pattern to surrounding structures (hypothalamus, optic chiasm). Cyst-solid-calcification triad is typical on MRI. Total resection is difficult during surgery (adherent tissue), recurrence rate 20-50%. Radiotherapy is effective for residual/recurrence.
Criteria
BRAF V600E mutation present in 95%; more prevalent in adults (peak 40-55 years), 30-40% of all craniopharyngiomas
Distinct Features
Predominantly solid mass, calcification rare (10%), cystic component smaller and serous (T1 hyperintensity less pronounced), more prominent homogeneous enhancement. Third ventricle location is common (less extrasellar). Less adherent to surrounding structures → surgical resection easier, recurrence rate lower (10-20%). BRAF inhibitors (dabrafenib + trametinib) show promising results in targeted therapy.
Criteria
Post-surgical residual or recurrence; months to years after primary treatment; recurrence rate 50-70% after subtotal resection, 10-20% after gross total resection
Distinct Features
New or growing enhancing tissue in surgical bed, cystic re-formation, difficult to distinguish from postoperative changes — serial follow-up is critical. DWI may be evaluated for new cyst formation. After radiotherapy, differentiating radiation necrosis from recurrence is challenging — perfusion MRI and spectroscopy are helpful. Risk of hypothalamic damage increases with repeat surgeries, so intracystic therapies (bleomycin, interferon) may be alternatives.
Distinguishing Feature
Pituitary adenoma is sellar in location with rare calcification and cystic component; shows homogeneous enhancement; no T1 hyperintense cyst signal; usually presents as solid mass; snowman appearance and diaphragma sellae waist sign typical with suprasellar extension
Distinguishing Feature
Epidermoid cyst shows marked diffusion restriction on DWI (low ADC) — craniopharyngioma does not show diffusion restriction; not fully suppressed on FLAIR; no enhancement; no calcification; typically located in cerebellopontine angle or parasellar region
Distinguishing Feature
Suprasellar meningioma is a solid mass with rare cystic component; shows homogeneous and intense enhancement; dural tail sign is characteristic; calcification may be in different pattern; no T1 hyperintense cyst component; usually shows broad dural-based attachment
Distinguishing Feature
Arachnoid cyst shows isointense signal to CSF on all sequences (T1 hypointense, T2 hyperintense, complete suppression on FLAIR); no calcification, solid component, or enhancement; no diffusion restriction on DWI; cyst wall not visible; no T1 hyperintense cyst signal
Urgency
urgentManagement
surgicalBiopsy
Not NeededFollow-up
Postoperatif MR 24-72 saat içinde (rezidü değerlendirme), ardından 3 ayda bir MR izlem (ilk 2 yıl), sonra 6 ayda bir; endokrinolojik takip ömür boyuWhile craniopharyngioma is histologically benign, it is a significant source of morbidity due to locally aggressive behavior and high recurrence rate. Treatment strategy is determined by tumor size, location, and hypothalamic involvement: aggressive surgery increases the risk of hypothalamic damage, while a conservative surgery + radiotherapy approach aims to preserve hypothalamic function. Endocrine disorders (panhypopituitarism, diabetes insipidus) occur in 80-90% of patients and require lifelong hormone replacement therapy. Visual field defects (bitemporal hemianopia) may improve with early surgical decompression. Obesity and neurocognitive problems are long-term consequences of hypothalamic damage.
Craniopharyngioma causes visual disturbances (bitemporal hemianopia), endocrine dysfunction (panhypopituitarism, diabetes insipidus), and hydrocephalus. Surgical resection is the primary treatment, but total resection is difficult due to hypothalamic adhesions. Subtotal resection + adjuvant radiotherapy is a common strategy. Recurrence rate is high.